Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Nintedanib Impurity 22

Nintedanib Impurity 22 is listed in the pharmaceutical impurity collection under CAS 676326-36-6. Its represented structure has formula C12H11NO4 and a calculated molecular weight of 233.22 g/mol.

2D chemical structure

O O N O O

Chemical identity

Catalog name
Nintedanib Impurity 22
Common name
Nintedanib Impurity 22
Chemical name
methyl 1-acetyl-2-oxo-3H-indole-6-carboxylate
CAS
676326-36-6
SMILES
COC(=O)c1ccc2c(c1)N(C(C)=O)C(=O)C2
InChI
InChI=1S/C12H11NO4/c1-7(14)13-10-5-9(12(16)17-2)4-3-8(10)6-11(13)15/h3-5H,6H2,1-2H3
InChIKey
QIMXPFXIAXDPBS-UHFFFAOYSA-N
Associated API
Nintedanib

Record ID: A6290a1641405

Computed properties

C12H11NO4 Molecular formula
233.223 g/molMolecular weight
233.0688 DaMonoisotopic exact mass
63.68 ŲTopological polar surface area
0.9088 Calculated LogP (Wildman–Crippen)
59.6525 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 3 6 9 12 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight233.22325.83
Calculated LogP (Wildman–Crippen)0.908824.08
Topological polar surface area63.6844.48
Hydrogen-bond acceptors450.68
Hydrogen-bond donors011.28
Rotatable bonds (strict)112.12

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC12H11NO4dimensionless
Molecular weight233.223g/mol
Monoisotopic exact mass233.0688Da
Topological polar surface area63.68Ų
Calculated LogP (Wildman–Crippen)0.9088dimensionless
Molar refractivity (Wildman–Crippen)59.6525cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors0count
Rotatable bonds (strict)1count
Heavy atoms17count
Heteroatoms5count
Rings2count
Aromatic rings1count
Aliphatic rings1count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.25fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area97.9732Ų
Valence electrons88count
Radical electrons0count
Bertz complexity521.237index
Balaban J2.4862index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Nintedanib Impurity 22

Qualification and safety assessment of Nintedanib Impurity 22

Explore toxicological qualification of Nintedanib Impurity 22 and ICH M7 mutagenic impurity assessment of Nintedanib Impurity 22 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Nintedanib Impurity 22 and acceptable intake and limit justification for Nintedanib Impurity 22. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Nintedanib Impurity 22

Explore Altox services and software through the Altox Pharma-Hub.